ARTICLE | Clinical News
GenPhar preclinical data
October 14, 2002 7:00 AM UTC
GenPhar said that in animals its vaccine gave 100% protection against challenge with Marburg virus, a hemorrhagic virus that GenPhar said is a potential biowarfare threat. The vaccine was developed un...